Skip to content

The effect of phenol on recurrent pilonidal sinus in 1404 (uncontrolled studies)

The effect of phenol on recurrent pilonidal sinus in 1404 (uncontrolled studies)

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20130826014483N13
Enrollment
31
Registered
2025-08-05
Start date
2025-08-10
Completion date
Unknown
Last updated
2025-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pilonidal cyst and sinus. Pilonidal cyst and sinus

Interventions

Intervention group:2-5 grams of crystallized phenol, made in Germany, is filled into the sinus with the help of a clamp, dissolves quickly at body temperature, excess phenol is removed from the sinus

Sponsors

Mazandaran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: People who present with recurrent pilonidal sinus

Exclusion criteria

Exclusion criteria: Unwillingness to participate in the study Those with incomplete information, as well as those who did not attend their regular follow-up visits or could not be contacted, were not included in the study. People who have diabetes

Design outcomes

Primary

MeasureTime frame
Reducing pain. Timepoint: 1, 5, 7 days after using the medicine. Method of measurement: Visual Analogue Scale.

Secondary

MeasureTime frame
Pilonidal sinus recurrence rate. Timepoint: 2 weeks after and 1 month after injection. Method of measurement: Clinical examination.;Itching. Timepoint: Days 3, 1, 5, 1 week later, 1 month later. Method of measurement: Clinical examination.;Burn. Timepoint: Days 3, 1, 5, 1 week later, 1 month later. Method of measurement: Clinical examination.;Abscess. Timepoint: Days 3, 1, 5, 1 week later, 1 month later. Method of measurement: Clinical examination.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMina Alvandipour

Mazandaran University of Medical Sciences

malvandipour@mazums.ac.ir+98 11 3336 1700

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026